Viscient Bio Inc

📍 San Diego, United States🗓 Founded 2017👥 12 employees💰 Last funded Aug 2020
Pharmaceutical Manufacturing🌐 viscientbiosciences.com
Website LinkedIn
We are focused on utilizing 3D culture technology to develop drugs across a range of therapeutic areas. Founded by a combination of former Organovo and Ardea Biosciences scientists and entrepreneurs, Viscient is initially conducting discovery and development work in non-alcoholic fatty liver disease (“NAFLD”) and non-alcoholic steatohepatitis (“NASH”). Utilizing newly available three dimensional biology technologies, we explore biology in a previously unavailable context, leading to a better understanding of disease and an improved opportunity to impact patients.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2017
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Viscient Bio Inc?
Viscient Bio Inc has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did Viscient Bio Inc last raise funding?
The most recent investment in Viscient Bio Inc recorded on gritt.io was in August 2020.
When was Viscient Bio Inc founded?
Viscient Bio Inc was founded in 2017.
What industry is Viscient Bio Inc in?
Viscient Bio Inc operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Viscient Bio Inc based?
Viscient Bio Inc is headquartered in San Diego, United States.